• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

管理 COVID-19 工具加速计划:促进更大程度的参与、透明度和问责制。

Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.

机构信息

International Relations and Political Science Department & Interdisciplinary Programmes, Global Health Centre, Graduate Institute of International and Development Studies, Geneva, Switzerland.

Independent Global Health Consultant, Geneva, Switzerland.

出版信息

Lancet. 2022 Jan 29;399(10323):487-494. doi: 10.1016/S0140-6736(21)02344-8. Epub 2021 Dec 11.

DOI:10.1016/S0140-6736(21)02344-8
PMID:34902308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8797025/
Abstract

The Access to COVID-19 Tools Accelerator (ACT-A) is a multistakeholder initiative quickly constructed in the early months of the COVID-19 pandemic to respond to a catastrophic breakdown in global cooperation. ACT-A is now the largest international effort to achieve equitable access to COVID-19 health technologies, and its governance is a matter of broad public importance. We traced the evolution of ACT-A's governance through publicly available documents and analysed it against three principles embedded in the founding mission statement of ACT-A: participation, transparency, and accountability. We found three challenges to realising these principles. First, the roles of the various organisations in ACT-A decision making are unclear, obscuring who might be accountable to whom and for what. Second, the absence of a clearly defined decision making body; ACT-A instead has multiple centres of legally binding decision making and uneven arrangements for information transparency, inhibiting meaningful participation. Third, the nearly indiscernible role of governments in ACT-A, raising key questions about political legitimacy and channels for public accountability. With global public health and billions in public funding at stake, short-term improvements to governance arrangements can and should now be made. Efforts to strengthen pandemic preparedness for the future require attention to ethical, legitimate arrangements for governance.

摘要

《COVID-19 工具加速计划(ACT-A)》是一项多方利益攸关方倡议,在 COVID-19 大流行的早期迅速构建,以应对全球合作的灾难性破裂。ACT-A 现在是实现公平获取 COVID-19 卫生技术的最大国际努力,其治理是一个广泛的公众关注的问题。我们通过公开可用的文件追溯了 ACT-A 治理的演变,并根据 ACT-A 的成立使命声明中嵌入的三个原则对其进行了分析:参与、透明和问责制。我们发现了实现这些原则的三个挑战。首先,ACT-A 决策中各种组织的角色不明确,模糊了谁可能对谁负责,以及负责什么。其次,没有明确界定决策机构;ACT-A 而是有多个具有法律约束力的决策中心,信息透明度的安排参差不齐,阻碍了有意义的参与。第三,政府在 ACT-A 中的作用几乎难以察觉,这引发了关于政治合法性和公众问责渠道的关键问题。由于全球公共卫生和数十亿美元的公共资金面临风险,现在可以而且应该对治理安排进行短期改进。为未来加强大流行病防备工作需要关注治理的伦理和合法安排。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e63/8797025/70391cd2c849/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e63/8797025/e10f1f5fa69b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e63/8797025/70391cd2c849/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e63/8797025/e10f1f5fa69b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e63/8797025/70391cd2c849/gr2_lrg.jpg

相似文献

1
Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.管理 COVID-19 工具加速计划:促进更大程度的参与、透明度和问责制。
Lancet. 2022 Jan 29;399(10323):487-494. doi: 10.1016/S0140-6736(21)02344-8. Epub 2021 Dec 11.
2
Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviews.共卫生治理、相互集体问责制以及 COVAX 的透明度:一项对文件抽样和关键知情人访谈数据进行三角分析的定性研究。
J Glob Health. 2023 Dec 8;13:04165. doi: 10.7189/jogh.13.04165.
3
Rethinking international financing for health to better respond to future pandemics.重新思考应对未来大流行病的国际卫生筹资。
BMJ Glob Health. 2023 Nov 24;8(11):e012988. doi: 10.1136/bmjgh-2023-012988.
4
International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.国际合作确保公平获取 COVID-19 疫苗:ACT-Accelerator 和 COVAX 设施。
Milbank Q. 2021 Jun;99(2):426-449. doi: 10.1111/1468-0009.12503. Epub 2021 Mar 2.
5
Implications from COVID-19 for future pandemic global health governance.2019冠状病毒病对未来大流行全球卫生治理的启示。
Clin Microbiol Infect. 2024 May;30(5):576-581. doi: 10.1016/j.cmi.2023.03.027. Epub 2023 Apr 1.
6
Governance arrangements for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的治理安排:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD011085. doi: 10.1002/14651858.CD011085.pub2.
7
Attributes of national governance for an effective response to public health emergencies: Lessons from the response to the COVID-19 pandemic.应对突发公共卫生事件的国家治理特征:从应对 COVID-19 大流行中获得的经验教训。
J Glob Health. 2022 Jul 6;12:05021. doi: 10.7189/jogh.12.05021.
8
COVAX and the rise of the 'super public private partnership' for global health.新冠疫苗全球免疫合作机制(COVAX)与全球卫生领域“超级公私伙伴关系”的兴起。
Glob Public Health. 2023 Jan;18(1):1987502. doi: 10.1080/17441692.2021.1987502. Epub 2021 Oct 22.
9
Challenges in international health financing and implications for the new pandemic fund.国际卫生融资面临的挑战及对新大流行病基金的影响。
Global Health. 2023 Dec 5;19(1):97. doi: 10.1186/s12992-023-00999-6.
10
An International Agreement on Pandemic Prevention and Preparedness.一项关于大流行预防和准备的国际协定。
JAMA. 2021 Oct 5;326(13):1257-1258. doi: 10.1001/jama.2021.16104.

引用本文的文献

1
The WHO Pandemic Agreement's Missing Epistemic Architectures: Infodemics and Antimicrobial Resistance as Examples.世界卫生组织大流行协定中缺失的认知架构:以信息疫情和抗微生物药物耐药性为例
Asian Bioeth Rev. 2025 Jul 16;17(3):495-514. doi: 10.1007/s41649-025-00387-9. eCollection 2025 Jul.
2
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security.减少全球医疗用氧获取方面的不平等:《柳叶刀》全球医疗用氧安全委员会
Lancet Glob Health. 2025 Mar;13(3):e528-e584. doi: 10.1016/S2214-109X(24)00496-0. Epub 2025 Feb 17.
3
Voices of Nanomedicine: Blueprint Guidelines for Collaboration in Addressing Global Unmet Medical Needs.

本文引用的文献

1
Embedding global access in development of future pandemic vaccines.将全球可及性纳入未来大流行疫苗的研发之中。
BMJ. 2021 Sep 20;374:n2256. doi: 10.1136/bmj.n2256.
2
The ACT Accelerator: heading in the right direction?ACT加速器:方向正确吗?
Lancet. 2021 Apr 17;397(10283):1419. doi: 10.1016/S0140-6736(21)00835-7.
3
Political legitimacy and research ethics.政治合法性与研究伦理。
纳米医学之声:应对全球未满足医疗需求的合作蓝图指南
ACS Nano. 2025 Jan 28;19(3):2979-2991. doi: 10.1021/acsnano.4c13513. Epub 2025 Jan 10.
4
'Our project, your problem?' A case study of the WHO's mRNA technology transfer programme in South Africa.“我们的项目,你的问题?” 世界卫生组织在南非的信使核糖核酸技术转让计划案例研究
PLOS Glob Public Health. 2024 Sep 23;4(9):e0003173. doi: 10.1371/journal.pgph.0003173. eCollection 2024.
5
COVID-19 ethics: unique aspects and a review as of early 2024.COVID-19 伦理:截至 2024 年初的独特方面和综述。
Monash Bioeth Rev. 2024 Jun;42(1):55-86. doi: 10.1007/s40592-024-00199-x. Epub 2024 Jul 13.
6
Confronting Inequalities and Bridging the Divide: A Retrospective Study Assessment of Country-Level COVID-19 Vaccine Equality with a Cox Regression Model.直面不平等并弥合差距:使用Cox回归模型对国家层面新冠疫苗公平性的回顾性研究评估
Vaccines (Basel). 2024 May 18;12(5):552. doi: 10.3390/vaccines12050552.
7
COVID-19 vaccine apartheid and the failure of global cooperation.新冠疫苗种族隔离与全球合作的失败
Br J Polit Int Relat. 2023 Aug;25(3):535-554. doi: 10.1177/13691481231178248. Epub 2023 Jun 13.
8
Challenges in international health financing and implications for the new pandemic fund.国际卫生融资面临的挑战及对新大流行病基金的影响。
Global Health. 2023 Dec 5;19(1):97. doi: 10.1186/s12992-023-00999-6.
9
Rethinking international financing for health to better respond to future pandemics.重新思考应对未来大流行病的国际卫生筹资。
BMJ Glob Health. 2023 Nov 24;8(11):e012988. doi: 10.1136/bmjgh-2023-012988.
10
The Dynamics of Power Flow From the Global Health Financing Comment on "Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process".全球卫生筹资评论中的权力流动动态:以尼日利亚卫生专业人员的权力动态为例研究全球基金政策进程。
Int J Health Policy Manag. 2023;12:7806. doi: 10.34172/ijhpm.2023.7806. Epub 2023 May 10.
Bioethics. 2019 Mar;33(3):312-318. doi: 10.1111/bioe.12489. Epub 2018 Aug 23.
4
Global public-private partnerships: Part II--What are the health issues for global governance?全球公私伙伴关系:第二部分——全球治理面临的健康问题有哪些?
Bull World Health Organ. 2000;78(5):699-709.